<DOC>
	<DOCNO>NCT02196909</DOCNO>
	<brief_summary>The objective study identify best clinical biological outcome measure therapeutic approach .</brief_summary>
	<brief_title>Clinical , Biological NMR Outcome Measures Study Hereditary Inclusion Body Myopathy Due Mutation UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine Kinase Gene ( GNE )</brief_title>
	<detailed_description />
	<criteria>Must least 18 year age . Must willing able provide consent . Must genetic diagnosis HIBM , GNE myopathy , Quadriceps Sparing Myopathy ( QSM ) , Inclusion Body Myopathy Type 2 , distal myopathy rim vacuole ( DMRV ) , Nonaka disease . Must willing able comply study requirement . Affiliated beneficiary social security category Must take part HIBMPMP UX001CL401 study Received ManNAc therapy similar substance Any unrelated , comorbid disease condition , view investigator , would interfere study participation would affect safety . Patients specific contraindication MRI ( i.e . metallic foreign body , claustrophobiaâ€¦ ) allow participate , MRI perform . Pregnant woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>HIBM</keyword>
	<keyword>GNE</keyword>
</DOC>